BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1006 related articles for article (PubMed ID: 19513946)

  • 1. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamer applications for targeted cancer therapy.
    Barbas AS; Mi J; Clary BM; White RR
    Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex target SELEX.
    Shamah SM; Healy JM; Cload ST
    Acc Chem Res; 2008 Jan; 41(1):130-8. PubMed ID: 18193823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology and aptamers: applications in drug delivery.
    Levy-Nissenbaum E; Radovic-Moreno AF; Wang AZ; Langer R; Farokhzad OC
    Trends Biotechnol; 2008 Aug; 26(8):442-9. PubMed ID: 18571753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cancer cells with nucleic acid aptamers.
    Cerchia L; de Franciscis V
    Trends Biotechnol; 2010 Oct; 28(10):517-25. PubMed ID: 20719399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in SELEX and application of aptamers in the central nervous system.
    Yang Y; Yang D; Schluesener HJ; Zhang Z
    Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemical biology of aptamers.
    Mayer G
    Angew Chem Int Ed Engl; 2009; 48(15):2672-89. PubMed ID: 19319884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamers: from bench side research towards patented molecules with therapeutic applications.
    Majumder P; Gomes KN; Ulrich H
    Expert Opin Ther Pat; 2009 Nov; 19(11):1603-13. PubMed ID: 19852719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleic acid aptamers as adjuncts to vaccine development.
    Becker KC; Becker RC
    Curr Opin Mol Ther; 2006 Apr; 8(2):122-9. PubMed ID: 16610764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer cell targeting using multiple aptamers conjugated on nanorods.
    Huang YF; Chang HT; Tan W
    Anal Chem; 2008 Feb; 80(3):567-72. PubMed ID: 18166023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleic acid aptamers targeting cell-surface proteins.
    Dua P; Kim S; Lee DK
    Methods; 2011 Jun; 54(2):215-25. PubMed ID: 21300154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ssDNA aptamers that recognize diclofenac and 2-anilinophenylacetic acid.
    Joeng CB; Niazi JH; Lee SJ; Gu MB
    Bioorg Med Chem; 2009 Aug; 17(15):5380-7. PubMed ID: 19604698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining SELEX and the yeast three-hybrid system for in vivo selection and classification of RNA aptamers.
    König J; Julius C; Baumann S; Homann M; Göringer HU; Feldbrügge M
    RNA; 2007 Apr; 13(4):614-22. PubMed ID: 17283213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection and characterization of DNA aptamers against VEGF165 with aptamer blotting method and its application.
    Ikebukuro K; Hasegawa H; Sode K
    Nucleic Acids Symp Ser (Oxf); 2007; (51):399-400. PubMed ID: 18029755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aptamers: selection and scope of applications].
    Chauveau F; Pestourie C; Tavitian B
    Pathol Biol (Paris); 2006 May; 54(4):251-8. PubMed ID: 16678359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic investigation of optimal aptamer immobilization for protein-microarray applications.
    Walter JG; Kökpinar O; Friehs K; Stahl F; Scheper T
    Anal Chem; 2008 Oct; 80(19):7372-8. PubMed ID: 18729475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleic acid-based aptamers as promising therapeutics in neoplastic diseases.
    Cerchia L; de Franciscis V
    Methods Mol Biol; 2007; 361():187-200. PubMed ID: 17172712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamers against extracellular targets for in vivo applications.
    Pestourie C; Tavitian B; Duconge F
    Biochimie; 2005; 87(9-10):921-30. PubMed ID: 15963620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-specific aptamer-mediated targeted drug delivery.
    Zhou J; Rossi JJ
    Oligonucleotides; 2011 Feb; 21(1):1-10. PubMed ID: 21182455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.